Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients-Reference-Cited by-同舟云学术

Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients

Published:2021-12 Issue: Volume:34 Page:79-82
ISSN:2666-1683
Container-title:European Urology Open Science
language:en
Short-container-title:European Urology Open Science

Author:

Benmerzoug Sulayman,Chevalier Mathieu F.,Villier Laura,Nguyen Sylvain,Cesson Valérie,Schneider Anna K.,Dartiguenave Florence,Rodrigues-Dias Sonia-Christina,Lucca Ilaria,Jichlinski Patrice,Roth Beat,Nardelli-Haefliger Denise,Derré Laurent^ORCID

Publisher

Elsevier BV

Subject

Urology

Reference16 articles.

1. Bladder cancer;Sanli;Nat Rev Dis Primers,2017

2. Bacillus Calmette-Guerin (BCG) therapy for bladder cancer: an update;Guallar-Garrido;Immunotargets Ther,2020

3. EAU guidelines on non–muscle-invasive urothelial carcinoma of the bladder: update 2016;Babjuk;Eur Urol,2017

4. Definitions, end points, and clinical trial designs for non–muscle-invasive bladder cancer: recommendations from the International Bladder Cancer Group;Kamat;J Clin Oncol,2016

5. The multifaceted immune regulation of bladder cancer;Schneider;Nat Rev Urol,2019

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationships of SIGLEC family-related lncRNAs with clinical prognosis and tumor immune microenvironment in ovarian cancer;Scientific Reports;2024-03-31

2. Single-cell transcriptome analysis reveals immunosuppressive landscape in overweight and obese colorectal cancer;Journal of Translational Medicine;2024-02-04

3. Innate Lymphoid Cells in Bladder Cancer: From Mechanisms of Action to Immune Therapies;Cancer Immunology Research;2023-12-07

4. Tumor cell-intrinsic and tumor microenvironmental conditions co-determine signaling by the glycoimmune checkpoint receptor Siglec-7;Cellular and Molecular Life Sciences;2023-05-30

5. Novel Therapeutic Strategies for BCG-unresponsive Non-muscle Invasive Bladder Cancer;annals of urologic oncology;2022-11-27